Smith ST and Szlaczky MC. Syringe plunger contamination by hazardous drugs: A comparative study. J Oncol Pharm Practice 2014; 20(5), published online March.
2.
WickCSlawsonMJorgensonJ. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. AJHP2003; 60: 2314–2320.
3.
HarrisonBPetersBBingM. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. AJHP2006; 63: 1736–1744.
4.
SessinkPConnorTJorgensonJ. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. J Oncol Pharm Pract2011; 17: 39–48.
5.
SessinkPJ. Reduction in surface contamination with cyclophosphamide in 30 US hospital pharmacies following implementation of a closed-system drug transfer device. Hosp Pharm2013; 48: 204–212.
